Technical Analysis for CRVS - Corvus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 8.24 -1.90% -0.16
CRVS closed down 1.9 percent on Wednesday, November 20, 2024, on 68 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
NR7 Range Contraction -1.90%
NR7-2 Range Contraction -1.90%
20 DMA Resistance Bearish -1.20%
NR7 Range Contraction -1.20%
Fell Below 20 DMA Bearish -3.29%
New Downtrend Bearish -3.29%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 18 hours ago
Down 3% about 23 hours ago
Fell Below Previous Day's Low about 23 hours ago
Down 2 % about 23 hours ago
Down 1% about 23 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies that are designed to harness the immune system to attack cancer cells. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that plan to initiate a Phase 1/1b clinical trial for adenosine, an immune checkpoint. The company also develops a product candidate, an anti-CD73 monoclonal antibody that inhibits the production of adenosine. Corvus Pharmaceuticals, Inc. was founded in 2014 and is based in Burlingame, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Immunology Immune System Cancer Immunotherapy Monoclonal Antibody Cancer Cell Immune Checkpoint Adenosine Oncology Therapies Cd73

Is CRVS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.0
52 Week Low 1.3
Average Volume 811,036
200-Day Moving Average 3.53
50-Day Moving Average 7.07
20-Day Moving Average 8.72
10-Day Moving Average 8.71
Average True Range 0.72
RSI (14) 51.92
ADX 27.75
+DI 19.27
-DI 21.31
Chandelier Exit (Long, 3 ATRs) 7.85
Chandelier Exit (Short, 3 ATRs) 9.19
Upper Bollinger Bands 9.60
Lower Bollinger Band 7.84
Percent B (%b) 0.23
BandWidth 20.18
MACD Line 0.38
MACD Signal Line 0.60
MACD Histogram -0.2123
Fundamentals Value
Market Cap 404.08 Million
Num Shares 49 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -12.88
Price-to-Sales 0.00
Price-to-Book 2.44
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.80
Resistance 3 (R3) 8.78 8.59 8.70
Resistance 2 (R2) 8.59 8.45 8.59 8.67
Resistance 1 (R1) 8.41 8.36 8.32 8.43 8.64
Pivot Point 8.22 8.22 8.17 8.22 8.22
Support 1 (S1) 8.04 8.08 7.95 8.06 7.84
Support 2 (S2) 7.85 7.99 7.85 7.81
Support 3 (S3) 7.67 7.85 7.78
Support 4 (S4) 7.69